Steven Bartlett with Dr. Alex Tatem
Peptides are emerging as highly targeted tools for weight loss and tissue repair, but regulatory battles are restricting public access to these biological therapies.
Peptides function as precise biological keys designed to bind with specific cellular locks, enabling highly targeted cellular responses without the widespread side effects common to traditional small-molecule drugs.
GLP-1 receptor agonists are a specific class of peptides changing the treatment of obesity by slowing gastric emptying, increasing insulin sensitivity, and helping reverse metabolic dysfunction.
Specific healing peptides, such as BPC-157 and TB-500, accelerate the body's natural recovery mechanisms by promoting new blood vessel growth and tissue repair directly at the site of injuries.